Anticancer activity of resveratrol-loaded gelatin nanoparticles on NCI-H460 non-small cell lung cancer cells

Biomedicine and Preventive Nutrition

Volumn 3, Issue 1, 2013, Pages 64-73

  Karthikeyan, S ^a   Prasad, Rajendra ^a   Ganamani, A ^b   Balamurugan, E ^a  

^a ANNAMALAI UNIVERSITY   (India)

^b CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Anticancer; Coacervation; Controlled release; Gelatin nanoparticles; Lung cancer; Resveratrol

Indexed keywords

DNA; GELATIN; GELATIN NANOPARTICLE; GLUTARALDEHYDE; HYDROGEN; NANOPARTICLE; REACTIVE OXYGEN METABOLITE; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; DNA DAMAGE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG SOLUBILITY; ENCAPSULATION; ERYTHROCYTE AGGREGATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROGEN BOND; IC 50; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SLOW DRUG RELEASE; SPECTROPHOTOMETRY; SUSTAINED DRUG RELEASE;

RICE STRIPE VIRUS; VITACEAE;

EID: 84875242332     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2012.10.009     Document Type: Article

References (35)

1. Brown J.S., Eraut D., Trask C. Age and the treatment of lung cancer. Thorax 1996, 51:564-568.
2. Tseng C.L., Su W.Y., Yen K.C., Yang K.C., Lin F.H. The use of biotinylated-EGF-modifi{ligature}ed gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 2009, 30:476-485.
3. Fremont L. Biological effects of resveratrol. Life Sci 2000, 66:663-673.
4. Signorelli P., Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 2005, 16:449-466.
5. Kang O., Jang H., Chae H.J., Oh H.S., Choi Y.C., Lee J.G. Antiinflammatory mechanisms of resveratrol in activated HMC-1 cells: Pivotal roles of NF-kB and MAPK. Pharmacol Res 2009, 59:330-337.
6. Lu Z., Cheng B., Hu Y.L., Zhan Y.H., Zou G.L. Complexation of resveratrol with cyclodextrins: Solubility and antioxidant activity. Food Chem 2009, 113:17-20.
7. Juan M.E., Buenafuente J., Casals I., Planas J.M. Plasmatic levels of trans-resveratrol in rats. Food Res Int 2002, 35:195-199.
8. Ader P., Wessmann A., Wolffram S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 2000, 28:1056-1067.
9. Windrum P., Morris T.C., Drake M.B., Niederwieser D., Ruutu T. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centers. Bone Marrow Transpl 2005, 36:601-603.
10. Jameela S.R., Kumary T.V., Lal A.V., Jayakrishnan A. Progesteroneloaded chitosan microspheres: a long acting biodegradable controlled delivery system. J Control Release 1998, 52:17-24.
11. Gabr Y., Assem N., Michael A., Fahmy L. Evaluation studies on oxypolygelatin and degraded gelatin as plasma volume expander. Arzneimittelforschung 1996, 46:763-766.
12. Young S., Wong M., Tabata Y., Mikos A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005, 109:256-274.
13. Manoj N., Dinesh M., Dubey V., Jain N.K. Development, characterization, and toxicity evaluation of amphotericin B - loaded gelatin nanoparticles. Nanomedicine 2008, 4:252-261.
14. Oppenheim R.C., Stewart N.F. The manufacture and tumor cell uptake of nanoparticles labeled with fluoroscein isothiocyanate. Drug Dev Ind Pharm 1979, 5:583-591.
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 1983, 65:55-63.
16. Karthikeyan S., Kanimozhi G., Prasad N.R., Mahalakshmi R. Radiosensitizing effect of ferulic acid on human cervical carcinoma cells in vitro. Toxicol In Vitro 2011, 25:1366-1375.
17. Prasad N.R., Karthikeyan A., Karthikeyan S., Reddy B.V. Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fi{ligature}brosarcoma cell line. Mol Cell Biochem 2011, 349:11-19.
18. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantifcation of low levels of DNA damage in individual cells. Exp Cell Res 1988, 175:184-191.
19. Caddeo C., Teskac K., Sinico C., Kristl J. Effect of resveratrol incorporated in liposomes on proliferation and UVB protection of cells. Int J Pharm 2008, 363:183-191.
20. Narayani R., Rao K.P. Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres. J Microencapsul 1994, 11:69-77.
21. Peng H., Xiong H., Li J., Xie M., Liu Y., Bai C., et al. Vanillin cross-linked chitosan microspheres for controlled release of resveratrol. Food Chem 2010, 21:23-28.
22. Maeda H., Sawa T., Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 2001, 74:47-61.
23. Ofokansi K., Winter G., Fricker G., Coester C., Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading delivery Eur J Pharm Biopharm 2010, 76:1-9.
24. Shenoy D., Little S., langer R., Amiji S. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations. Mol Pharm 2005, 2:357-366.
25. Xiaowei L., Chenbo J.I., Huae X., Xiaolin L.I., Haixia D., Min Y., et al. Resveratrol-loaded polymeric micelles protect cells from Aβ-induced oxidative stress. Int J Pharm 2009, 375:89-96.
26. Filomeni G., Graziani I., Rotilio G., Ciriolo M.R. Trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr 2007, 2:295-305.
27. Shao J., Li X., Lu X., Jiang C., Hu Y., Li Q., et al. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells are mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf B Biointerfaces 2009, 72:40-47.
28. Cao Y., Wang F., Liu H.Y., Fue Z.D., Heen R. Resveratrol induces apoptosis and differentiation in acute promyelocytic leukemia (NB4) cells. J Asian Nat Prod Res 2005, 7:633-641.
29. Chen Z., Jin K., Gao L., Lou G., Jin Y., Yu Y., et al. Antitumor effects of bakuchiol, an analogue of resveratrol, on human lung adenocarcinoma A549 cell line. Eur J Pharmacol 2010, 643:170-179.
30. Shimizu T., Nakazato T., Xian M.J., Sagawa M., Ikeda Y., Kizaki M. Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways. Biochem Pharmacol 2006, 71:742-750.
31. Tsujimoto Y., Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 2007, 12:835-840.
32. Zhou H.B., Yan Y., Sun Y.N., Zhu J.R. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J Gastroenterol 2003, 9:408-411.
33. Das S., Ng K.Y. Resveratrol-loaded calcium-pectinate beads: effects of formulation parameters on drug release and bead characteristics. J Pharm Sci 2010, 99:840-860.
34. Frozza R.L., Bernardi A., Paese K., Hoppe J.B., Silva T., Battastini A.M., et al. Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. J Biomed Nanotechnol 2010, 6:694-703.
35. Narayanan N.K., Nargi D., Randolph C., Narayanan B.A. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN-knockout mice. Int J Cancer 2009, 125:1-8.